تجاوز إلى المحتوى الرئيسي

بحث

عنوان الدراسة داعم الدراسة حالة الدراسة دواء الدراسة مرحلة الدراسة رقم بروتوكول الدراسة موقع الدراسة
A Multicentre, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe Uncontrolled Asthma (NAVIGATOR) AstraZeneca Ongoing Tezepelumab 3 D5180C00007 King Abdulaziz University Hospital (Jeddah), King Khalid University Hospital (Riyadh), King Abdulaziz Medical City NG (Jeddah)
Phase 2, Multi-Center, Double-Blind, Randomized, 2-Arm, Parallel Study to Assess the Efficacy and Safety of Ryanodex (EGL-4104) as Adjuvant Treatment in Subjects with Exertional Heat Stroke (EHS) Eagle Pharmaceuticals Ongoing Dantrolene 2 EGL-4104-C-1801 King Faisal General Hospital (Makkah), Mina Al-Jisr Hospital, Mina Al-Wadi Hospital, Mina Al-Shari' Al-Jadid Hospital
A two part seamless, open label, multi-center study to investigate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of RO7034067 in infants with type 1 spinal muscular atrophy. Roche Terminated Risdiplam 2 BP39056 King Faisal Specialist Hospital and Research Center (Riyadh)
"AURIGA / An observationAl stUdy pRogram toInvestiGate the effectiveness of intravitreal Aflibercept indiabetic macular edema and/or macular edema secondary toretinal vein occlusion in a real world setting." Bayer Ongoing Aflibercept 4 191 57 King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah), King Khalid University Hospital (Riyadh)
The effect of cinnamon supplementation on ovulation induction in women with polycystic ovary syndrome, Jeddah 2018: Randomized Double-Blind Placebo-controlled trial King Abdulaziz University (Jeddah) Ongoing Cinnamon 3 100-18 King Abdulaziz University Hospital (Jeddah)
Apixaban in Patients with Left Ventricular Thrombus, CLEAN-LV Study Saud Al Babtain Cardiac Center Ongoing Apixaban 4 2018-08 Saud Al-Babtain Cardiac Center (Dammam)N/A
An observational, prospective cohort study to evaluate the safety and effectiveness of Remsima® in the treatment of inflammatory bowel disease among Saudi Arabia patients diagnosed with Crohn’s disease, ulcerative colitis, or fistulizing CD Hikma Pharmaceuticals Ongoing Remsima 4 RMS-KSA-20 King Abdulaziz University Hospital (Jeddah)
Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma SWOG (Southwest Oncology Group) Ongoing Ibrutinib 3 A051301 King Faisal Specialist Hospital and Research Center (Riyadh)
OPEN LABEL, RANDOMIZED, SINGLE SITE CLINICAL TRIAL TO COMPARE THE SAFETY & EFFICACY OF HERBAL MELANIN EXTRACTED FROM NIGELLA SATIVA SEEDS VS STANDARD OF CARE TREATMENT IN TREATING GASTRITIS PATIENTS KAIMRC Rejected Melanole NIGELLA SATIVA 2 RC15/152/R N/A
Randomized, two-way, two-period, single injectable dose, open-label, crossover, bioequivalence study to compare Enoxa pre-filled syringes (80 mg enoxaparin sodium) versus Clexane® pre-filled syringes (80 mg enoxaparin sodium), in healthy subjects under fasting condition. MEDIS Laboratories Ongoing Enoxa / Enoxaparin BE 21-2017 v.02 Saudi Ajal
عرض 281 - 290 من 514